These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 16972068

  • 1. Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphoma.
    Gerber DE, Grossman SA, Batchelor T, Ye X.
    Cancer Chemother Pharmacol; 2007 May; 59(6):817-23. PubMed ID: 16972068
    [Abstract] [Full Text] [Related]

  • 2. Renal dysfunction during and after high-dose methotrexate.
    Green MR, Chamberlain MC.
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):599-604. PubMed ID: 18504579
    [Abstract] [Full Text] [Related]

  • 3. Results of treatment of 112 cases of primary CNS lymphoma.
    Yamanaka R, Morii K, Shinbo Y, Homma J, Sano M, Tsuchiya N, Yajima N, Tamura T, Hondoh H, Takahashi H, Kakuma T, Tanaka R.
    Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337
    [Abstract] [Full Text] [Related]

  • 4. Occult renal impairment is common in patients with peripheral vascular disease and normal serum creatinine.
    Rashid ST, Salman M, Agarwal S, Hamilton G.
    Eur J Vasc Endovasc Surg; 2006 Sep; 32(3):294-9. PubMed ID: 16716614
    [Abstract] [Full Text] [Related]

  • 5. [Effects of infusion duration of high-dose methotrexate on cerebrospinal fluid drug levels in lymphoma patients].
    Lin XB, Zhou NN, Li S, Cai QQ, Xia ZJ, Liao H, Gao Y, Huang HQ.
    Ai Zheng; 2008 Oct; 27(10):1100-5. PubMed ID: 18851792
    [Abstract] [Full Text] [Related]

  • 6. Formulas calculating creatinine clearance are inadequate for determining eligibility for Cisplatin-based chemotherapy in bladder cancer.
    Raj GV, Iasonos A, Herr H, Donat SM.
    J Clin Oncol; 2006 Jul 01; 24(19):3095-100. PubMed ID: 16809735
    [Abstract] [Full Text] [Related]

  • 7. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
    Poortmans PM, Kluin-Nelemans HC, Haaxma-Reiche H, Van't Veer M, Hansen M, Soubeyran P, Taphoorn M, Thomas J, Van den Bent M, Fickers M, Van Imhoff G, Rozewicz C, Teodorovic I, van Glabbeke M, European Organization for Research and Treatment of Cancer Lymphoma Group.
    J Clin Oncol; 2003 Dec 15; 21(24):4483-8. PubMed ID: 14597741
    [Abstract] [Full Text] [Related]

  • 8. [High-dose methotrexate followed by whole-brain irradiation for primary central nervous system lymphoma patients--a retrospective study in a single institute].
    Usui N, Dobashi N, Yano S, Yahagi Y, Takei Y, Otsubo H, Takahara S, Yamaguchi Y, Saito T, Minami J, Kamiyama Y, Morikawa N, Machishima T, Osawa H, Aiba K.
    Gan To Kagaku Ryoho; 2010 Jul 15; 37(7):1277-82. PubMed ID: 20647709
    [Abstract] [Full Text] [Related]

  • 9. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
    Bacci G, Ferrari S, Longhi A, Forni C, Loro L, Beghelli C, Tremosini M, Versari M.
    Oncol Rep; 2003 Jul 15; 10(4):851-7. PubMed ID: 12792734
    [Abstract] [Full Text] [Related]

  • 10. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.
    J Eur Acad Dermatol Venereol; 2008 Jan 15; 22(1):19-24. PubMed ID: 18031504
    [Abstract] [Full Text] [Related]

  • 11. Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up.
    Omuro AM, DeAngelis LM, Yahalom J, Abrey LE.
    Neurology; 2005 Jan 11; 64(1):69-74. PubMed ID: 15642906
    [Abstract] [Full Text] [Related]

  • 12. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P, Oviedo I, Campbell M, Tordecilla J.
    Pediatr Blood Cancer; 2004 Jul 11; 43(1):17-22. PubMed ID: 15170885
    [Abstract] [Full Text] [Related]

  • 13. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
    Iseki K, Kinjo K, Iseki C, Takishita S.
    Am J Kidney Dis; 2004 Nov 11; 44(5):806-14. PubMed ID: 15492946
    [Abstract] [Full Text] [Related]

  • 14. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN, Isakow W, Doherty JA, Micek ST, Kollef MH.
    Clin Ther; 2007 Jun 11; 29(6):1107-15. PubMed ID: 17692725
    [Abstract] [Full Text] [Related]

  • 15. The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patients.
    Kasenda B, Rehberg M, Thürmann P, Franzem M, Veelken H, Fritsch K, Schorb E, Finke J, Lebiedz D, Illerhaus G.
    Ann Hematol; 2012 Aug 11; 91(8):1257-64. PubMed ID: 22456893
    [Abstract] [Full Text] [Related]

  • 16. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.
    Shah GD, Yahalom J, Correa DD, Lai RK, Raizer JJ, Schiff D, LaRocca R, Grant B, DeAngelis LM, Abrey LE.
    J Clin Oncol; 2007 Oct 20; 25(30):4730-5. PubMed ID: 17947720
    [Abstract] [Full Text] [Related]

  • 17. [Severe renal impairment of methotrexate elimination after high dose therapy].
    Lawrenz-Wolf B, Wolfrom C, Frickel C, Fengler R, Wehinger H, Henze G.
    Klin Padiatr; 1994 Oct 20; 206(4):319-26. PubMed ID: 7967432
    [Abstract] [Full Text] [Related]

  • 18. Mobilization of hemopoietic stem cells with high-dose methotrexate plus granulocyte-colony-stimulating factor in patients with primary central nervous system lymphoma.
    Kiefer T, Krüger WH, Montemurro M, Schüler F, Hirt C, Pasold R, Niederwieser D, Schwenke M, Dölken G.
    Transfusion; 2008 Dec 20; 48(12):2624-8. PubMed ID: 18801020
    [Abstract] [Full Text] [Related]

  • 19. Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies.
    Xu WQ, Zhang LY, Chen XY, Pan BH, Mao JQ, Song H, Li JY, Tang YM.
    Cancer Chemother Pharmacol; 2014 Jan 20; 73(1):79-86. PubMed ID: 24158402
    [Abstract] [Full Text] [Related]

  • 20. Creatinine clearance estimation from serum creatinine values: evaluation and comparison of five prediction formulae in Nigerian patients.
    Sanusi AA, Akinsola A, Ajayi AA.
    Afr J Med Med Sci; 2000 Mar 20; 29(1):7-11. PubMed ID: 11379474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.